Evidence map›Paper›PMID 41860131›Full record

ArticlePlant biotechnology journal2026

Production of the High Value Pharmaceutical Target, Human Granulocyte-Colony Stimulating Factor, in Nicotiana benthamiana Is Improved by Co-Expression of the Transcriptional Regulator of the Unfolded Protein Response, bZIP60.

Nazgul Wagner, Konstantin Musiychuk, Stephen Tottey, Jukka Kervinen, Hong Bi, Stephen J Streatfield, Rainer Fischer, Vidadi Yusibov

Abstract read
In one paragraph

Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nazgul WagnerFraunhofer USA Inc., Center Mid-Atlantic, Biotechnology Division, Newark, Delaware, USA.ORCID https://orcid.org/0009-0009-0247-3569
Konstantin MusiychukFraunhofer USA Inc., Center Mid-Atlantic, Biotechnology Division, Newark, Delaware, USA.
Stephen TotteyFraunhofer USA Inc., Center Mid-Atlantic, Biotechnology Division, Newark, Delaware, USA.
Jukka KervinenFraunhofer USA Inc., Center Mid-Atlantic, Biotechnology Division, Newark, Delaware, USA.
Hong BiFraunhofer USA Inc., Center Mid-Atlantic, Biotechnology Division, Newark, Delaware, USA.
Stephen J StreatfieldFraunhofer USA Inc., Center Mid-Atlantic, Biotechnology Division, Newark, Delaware, USA.
Rainer FischerRWTH Aachen University, Institute for Molecular Biotechnology, Aachen, Germany.
Vidadi YusibovFraunhofer USA Inc., Center Mid-Atlantic, Biotechnology Division, Newark, Delaware, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41860131
PMCPMC13398621

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.